[Ip-health] Reminder! Register for panel event WHA72 Friday 24 May on CART and CRISPR

Claire Cassedy claire.cassedy at keionline.org
Sun May 19 23:40:46 PDT 2019

24 May 2019 – KEI panel discussion – Assessing the implications of the
development of new cell and gene-based therapies (including CAR T and
CRISPR): What role should WHO play?

On Friday, 24 May 2019, Knowledge Ecology International (KEI) will convene
an expert panel from 12h30 to 14h30 in Espace Henry Dunant at the Red Cross
Museum located at Avenue de la Paix 17, Geneva. An example of the potential
role the WHO secretariat could play is producing a report on potential
intellectual property and regulatory barriers for cell and gene-based
therapies including but not limited to CAR T and CRISPR.

*Date: Friday, 24 May 2019Time: 12h30 to 14h30Location: Espace Henry
Dunant, Red Cross Museum, Avenue de la Paix 17, Geneva*

Registration is required. Please contact Thiru Balasubramaniam: thiru[at]
keionline.org or Claire Cassedy: claire.cassedy[at]keionline.org to


   - Dr. Luca Li Bassi, Director General, Agenzia Italiana del Farmaco
   - Dr. Hannes Braberg, Staff Scientist, University of California, San
   - James Love, Director, Knowledge Ecology International (KEI)
   - Dr. Els Torreele, Executive Director, Médecins Sans Frontières (MSF)
   Access Campaign
   - Salome Meyer, Project Manager, Access to Medicine, Cancer Alliance
   - Dr. Nicola Magrini, Secretary, WHO Expert Committee on the Selection
   and Use of Essential Medicines, World Health Organization (WHO)

Moderator: Dr Tido von Schoen-Angerer, Board Member, KEI Europe

More information about the Ip-health mailing list